Applied Sciences Inc.

Manufacturers of COVID-19 tests that reached the market via the emergency use authorization (EUA) process will need to collect additional information to help mitigate risks posed by viral mutations, t

If large diagnostics companies are consolidating at a record pace these days, smaller companies are also struggling for ways to cope with the brutalities of the current market. Some are cutting back o

Genetic testing is progressing at a faster pace than anyone envisioned just a few years ago, based on the recent flurry of deal-making in the field. The question now is not whether genetic testing wil